MedTrace Logo

Examining Hair to Determine Tenofovir Exposure

NCT00903084 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2015-04-06

No results posted yet for this study

Summary

This study will determine whether a hair test can reveal how much of the anti-HIV medication tenofovir a person without HIV has been exposed to.

Conditions

Interventions

DRUG

Tenofovir Disoproxil Fumarate

300-mg tablet

Sponsors & Collaborators

  • National Institute of Mental Health (NIMH)

    collaborator NIH

  • Public Health Foundation Enterprises, Inc.

    lead OTHER

Principal Investigators

  • Albert Liu, MD, MPH · San Francisco Department of Public Health

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-06-30
Primary Completion
2010-06-30
Completion
2010-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00903084 on ClinicalTrials.gov